TrialClinical and translational gastroenterology2019

Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.

Yoshikazu Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.